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ABSTRACT 
 
The Institute of Medicine (IOM) of the National Academy of Sciences recently completed a 
critical review of the scientific literature pertaining to the association of indoor dampness and 
mold contamination with adverse health effects.  In this paper, we report the results of 
quantitative meta-analysis of the studies reviewed in the IOM report.  We developed point 
estimates and confidence intervals (CIs) to summarize the association of several respiratory and 
asthma-related health outcomes with the presence of dampness and mold in homes.  The odds 
ratios and confidence intervals from the original studies were transformed to the log scale and 
random effect models were applied to the log odds ratios and their variance.  Models were 
constructed both accounting for the correlation between multiple results within the studies 
analyzed and ignoring such potential correlation.  Central estimates of ORs for the health 
outcomes ranged from 1.32 to 2.10, with most central estimates between 1.3 and 1.8.  
Confidence intervals (95%) excluded unity except in two of 28 instances, and in most cases the 
lower bound of the CI exceeded 1.2.  In general, the two meta-analysis methods produced similar 
estimates for ORs and CIs.  Based on the results of the meta-analyses, building dampness and 
mold are associated with approximately 30% to 80% increases in a variety of respiratory and 
asthma-related health outcomes.  The results of these meta-analyses reinforce the IOM’s 
recommendation that actions be taken to prevent and reduce building dampness problems. 
 
 
INTRODUCTION 
 
The association of adverse health effects with dampness and mold in buildings has been the 
subject of much research.  Most studies on this topic have found an increased risk of one or more 
adverse health effects in buildings with signs of dampness or visible mold.  The Institute of 
Medicine (IOM) of the National Academy of Sciences recently completed a critical review (IOM 
2004) of this scientific literature.  The IOM concluded that excessive indoor dampness is a public 
health problem, noted that dampness problems are common, and recommended corrective 
measures.  While the IOM report summarized the main features and results of the reviewed 
studies, which included a broad range of health outcomes, it provided no quantitative summaries 
of these studies.   
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In this paper, we report the results of quantitative meta-analyses of the studies reviewed in the 
IOM report. A meta-analysis uses statistical methods to combine data from different but 
comparable research studies, in order to provide a quantitative summary on the size and 
variability of an association.  Studies are generally selected for relevance, quality, and similarity.  
The contribution of larger, more precise studies to the summary estimate is generally more 
heavily weighted.  Results of meta-analyses presented here are central point estimates and 
confidence intervals (CIs) of odds ratios (ORs) that summarize the magnitude of increased risk 
of several health outcomes in buildings with dampness and mold.  The central estimates and CIs 
of ORs, if assumed to reflect causality, can be used to communicate the importance of dampness 
and mold as health risks, to estimate the economic significance of dampness- and mold-related 
health effects to society, and to estimate the magnitude of health and economic benefits from 
programs that reduce dampness and mold.  
 
 
METHODS 
 
We began with the full list of studies included in Tables 5-1, 5-2, 5-3, 5-6, 5-7, 5-8 of the recent 
IOM review (IOM 2004).  Details on the studies included in the meta-analyses are provided in 
Appendix 1.  
 
Ideally, meta-analyses would combine estimates only from studies with the same precisely 
defined health outcome, risk factor, and population/subjects.  Because the original studies 
included many differently defined respiratory health outcomes, risk factors, and populations, this 
was not possible, and we analyzed groups of studies that were as similar as practicable with 
respect to these.  Table 1 shows the health outcome categories and specific outcomes from the 
studies included in each category.  
 
Subject types 
We grouped studies by subject type.  The reviewed studies included diverse populations: adults, 
male adults, female adults, children (age < 18), and children (infants).  We performed, where 
possible, separate analyses for: adults (including studies of mixed or single gender), children 
(including studies of age < 18 or infants), and all ages combined.  However, for ever-diagnosed 
with asthma and asthma development, too few studies were available to support separate meta-
analyses for children and adults.  
 
Risk factors 
In general, the risk factors in the reviewed studies included were visible signs of dampness, 
visible mold, dampness or mold, dampness and mold, and measured concentrations of airborne 
mold spores or related agents of microbial origin.  We included in meta-analyses only the studies 
with reports of dampness and/or mold as risk factors1.  A large majority of all studies used these 
risk factors.  We did not distinguish among dampness, mold, dampness or mold, and dampness 
and mold as risk factors.  Our rationale – visible mold is always considered the result of excess 
dampness, whether or not the dampness is reported, and excess dampness is very often  
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Table 1. Health outcomes from reviewed studies, grouped into outcome categories used in 
meta-analysis 
Outcome 
Category for 
the Meta-
Analysis 
Outcomes from Individual Studies Used in Each Category 
 
Upper 
respiratory 
tract (URT) 
symptoms 
irritated, stuffy, or runny nose; nasal symptom; nasal congestion; nasal congestion or 
runny nose; nasal excretion; nose irritation; rhinitis; sinusitis; allergic rhinitis; allergy; 
hay fever 
Cough cough; cough with phlegm; cough without phlegm; day or night cough; dry cough; 
morning cough; long-term cough; night cough with wheeze; persistent cough 
Wheeze wheeze; persistent wheeze; wheeze apart from cold; wheeze including shortness of 
breath and asthma; wheeze/breathlessness 
Ever 
diagnosed 
with asthma 
• positive response to -- has a doctor ever diagnosed mother (father) to have attacks 
of shortness of breath (asthma)2;  
• positive response to-- did a doctor ever diagnose your having attacks of shortness 
of breath or asthma?;  
• physician-diagnosed asthma;  
• physician-diagnosed asthma, ever (atopic and non-atopic);  
• physician diagnosis of asthma since age > 16; 
• self-reported physician-diagnosed or nurse-diagnosed asthma 
Current 
asthma 
• current physician-diagnosed asthma, defined as diagnosis plus symptoms in last 12 
months;   
• ever doctor-diagnosed asthma plus asthma symptoms or medication in past 12 
months;  
• current asthma defined as combination of bronchial hyper-responsiveness and at 
least one of wheeze or breathlessness in last 12 months;  
• subjective symptoms of asthma plus one or more of the following: doctor 
diagnosed asthma attack and the disappearance of wheezing; doctor diagnosed 
asthma attack and > 15% decrease in PEF or FEV1; > 15% decrease in PEF or 
FEV1 in exercise test; > 20% daily variation in PEF at least 2 days per week in 4 
weeks of tracking; > 15% rise in PEF or FEV1 in a bronchodilating test;  
• asthma - current and diagnosed by physician; 
• current asthma diagnosed by a doctor -- text implies that current refers to the last 
12 months; 
• asthma currently present and reported to be confirmed by a physician; 
• occurrence of doctor diagnosed asthma in past year; 
• positive response to following two questions -- has your doctor ever said your 
child has asthma? does he or she still have asthma? 
Asthma 
development 
• newly doctor-diagnosed cases of asthma in past 2.5 years; 
• physician diagnosis of asthma since age > 16;  
• first time diagnosis of asthma 
 
accompanied by mold, although the mold may not be visible.  Thus, it is not possible to make a 
clean distinction among these risk factors.  We excluded from the meta-analyses ORs from 
                                                 
2 The question’s wording reflects the fact that the study assessed the risk of asthma in mothers and fathers of school 
children as a function of dampness in the home as part of a broader study focusing on children’s asthma symptoms  
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studies with measured concentrations of microbial agents or measured or reported high air 
humidity (Appendix 2). 
 
Presence of dampness and/or mold were made in each study by either the occupants or the 
researchers.  We did not distinguish between occupant-reported dampness and/or mold and 
researcher-reported dampness and/or mold.  Most studies that have compared occupant reports 
and researcher reports of dampness and/or mold have found the two types of reports to be fairly 
well correlated. Also, whether or not researcher-based reports are more accurate is still a subject 
of debate.  
 
The large majority of studies have assessed the risks of dampness and/or mold in homes.  ORs 
associated with dampness and/or mold in other types of buildings, such as schools or work 
places, were excluded from our analyses (Appendix 2).   
 
Health outcome categories  
For the non-asthma outcomes of upper respiratory tract (URT) symptoms, cough, and wheeze 
(Table 1), we categorized the health outcomes as in the IOM report (IOM 2004).  The URT 
symptom category included the broadest set of health outcomes, but nasal symptoms 
predominated.   
 
For asthma outcomes, however, based on review of the original papers, we developed different 
outcome categories than were used in the IOM report (IOM 2004).  Our asthma development 
category included ORs from studies that attempted to assess whether the development of asthma, 
as opposed to presence of asthma symptoms, was associated with dampness and mold; however, 
the associated time period for the asthma diagnosis or development ranged widely and there were 
few studies in this category.   
 
Several studies were excluded from meta-analyses because of outcomes used (Appendix 2).  For 
the asthma diagnosis and development categories, we excluded ORs from Wever-Hess et al. 
(2000) and Oie et al. (1999), with outcomes of asthma diagnosis or bronchial obstruction in 
children with an age less than 2, because it is not clear that asthma can be diagnosed before age 
2.  We excluded results from a single study performed in rural Kenya (Mohamad et al. 1995) 
because the living and health care conditions in this study population were distinctively different 
from those in other studies.  The ORs from Pihronen et al (1996) were also excluded because 
they indicated the odds of having one or more of a diverse set of outcomes (asthma, hay fever, 
allergic rhinitis, or eczema).   
 
Statistical methods 
Some of the reviewed studies reported separate estimates for multiple outcomes within the same 
subjects in the same study.  Because these findings within the same study may not be statistically 
”independent,” ignoring this dependence within a meta-analysis might overestimate the number 
of truly independent inputs to the summary model, and thus overestimate the precision of the 
summary estimates produced.  These meta-analyses use “random effect” models, which assume a 
single fixed mean effect (i.e., the association between the risk and the outcome in each model) 
across all studies, plus a random component that varies across studies or sub-studies.  Random 
effect models can estimate any within-study correlations included in the meta-analysis, and 
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adjust the estimates produced as necessary.  Such adjustment makes little difference in point 
estimates, but may increase the confidence interval for estimates.  We used the SAS procedure 
PROC MIXED, which allows fixing the within-study variances (matrix R in SAS) while 
estimating between-study variance (matrix G in SAS) at a different level.   
 
The odds ratios and 95% confidence intervals reported in each reviewed study were first 
transformed to the log scale.  The transformed results were then combined using a random effect 
model (DerSimonian & Laird, 1986).  Models were constructed both accounting for the 
correlation between multiple results within studies (“dependent sub-studies”), and ignoring such 
potential correlation (“independent sub-studies”).  
 
The model for independent sub-studies was 
yij ~ N(β0+β0ij, )     (1) 2ijσ
The model for dependent sub-studies was  
yij ~ N(β0+β0i, )      (2) 2ijσ
where: 
yij is the ln OR in jth sub-study of ith study; 
β0 is the fixed effect across all studies; 
β0ij is the random effect in the jth sub-study of the ith study; 
β0ij  ~ N(0, );  is the between-sub-study variance; 2σ 2σ
β0i :is the random effect in the ith study. β0i  ~ N(0, );  2*σ
2*σ  is the between-study variance; and  
2
ijσ  is the within-study variance, calculated from log confidence interval. 
 
 
RESULTS 
 
Major results of the meta-analyses are summarized in Table 2.  (Appendix 3 shows, as an 
example, ORs and CIs for the association of wheeze with dampness and mold in the original 
studies, and also from the summary estimates produced in the meta-analysis.)  Central estimates 
of ORs ranged from 1.32 to 2.10, with most central estimates between 1.3 and 1.8.  Confidence 
intervals (95%) excluded unity for 26 of 28 analyses, and in most cases the lower bound of the 
CI exceeded 1.2.  In general, the two meta-analysis methods produced similar estimates for ORs 
and CIs.  ORs for health effects in children were not consistently larger or smaller than 
corresponding ORs for adults.  CIs tended to be smaller for analyses including both adults and 
children, presumably because of the larger numbers of studies.  CIs for asthma development 
were broad, with lower bounds near unity, presumably because the analyses included data from 
only three studies.   
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Table 2.  Key results of the meta-analyses 
Outcome Subjects # of Studies 
Odds Ratio 
Random-Effect Model 
Dependent 
Sub-studies 
Odds Ratio 
Random-Effect Model 
Independent  
Sub-studies 
All 10 1.53 (1.26-1.87) 1.54 (1.33-1.78) 
Adults 6 1.39 (1.12-1.71) 1.37 (1.17-1.59) 
Upper 
respiratory 
tract 
symptoms Children 4 1.92 (1.08-3.41) 2.04 (1.41-2.96) 
All 19 1.77 (1.47-2.12) 1.79 (1.57-2.03) 
Adults 5 2.10 (1.27-3.47) 2.04 (1.55-2.68) Cough 
Children 14 1.62 (1.35-1.94) 1.65 (1.44-1.88) 
All 16 1.81 (1.45-2.26) 1.65 (1.48-1.83) 
Adults 3 1.68 (1.14-2.49) 1.66 (1.42-1.95) Wheeze 
Children 13 1.91 (1.42-2.57) 1.65 (1.43-1.90) 
All 10 1.51 (1.40-1.62) 1.51 (1.41-1.61) 
Adults 3 1.82 (1.28-2.59) 1.82 (1.52-2.19) Current asthma Children 7 1.45 (1.33-1.58) 1.45 (1.34-1.57) 
Ever 
diagnosed 
asthma 
All 8 1.59 (1.26-2.00) 1.70 (1.42-2.04) 
Asthma 
development All 3 1.39 (0.69-2.80) 1.32 (.98-1.77) 
 
 
DISCUSSION 
 
Importance of building dampness 
Based on the meta-analyses described in this report, building dampness and mold are associated 
with 30% to 80% increases3 in a variety of health outcomes in a variety of populations.  These 
associations are statistically significant – with 95% CIs excluding unity -- in almost all cases.  
The similar results obtained from two analysis methods suggest little problem with correlation of 
health outcomes within studies.  Statistical associations do not prove that dampness and mold are 
causally related to the health outcomes.  Building dampness itself is very unlikely to directly 
cause adverse health effects.  However, the consistent and relatively strong associations of 
dampness with adverse health effects strongly suggest causation by dampness-related exposures.  
Building dampness may cause the building to become contaminated with microorganisms such 
                                                 
3 The 30% to 80% increase in symptoms is an approximate estimate based on the central estimates of the ORs for 
the various health outcomes in Table 2.  When the health outcome prevalence is below approximately 15%, which is 
typically the case for wheeze and asthma-related outcomes, the percentage increase in the outcome among the 
population experiencing the risk factor (e.g., dampness) is well estimated by 100%(1-OR).  The central estimates of 
ORs for these health outcomes ranges from 1.32 to 1.91, implying a 33% to 91% increase in health outcome 
prevalence.  However, when the prevalence of the outcome is substantially higher than 15%, as is often the case for 
URT symptoms and cough, this simple calculation overestimates the percentage increase in the outcome in the 
population with the risk factor.  For example, assuming an outcome prevalence of 0.3 for URT symptoms and cough 
in the population with dampness, the OR in Table 2 of 1.79 for cough indicates a 53% increase in cough among the 
exposed population and the OR of 1.54 in Table 2 for URT symptoms indicates a 38% increase in URT symptoms 
among the exposed population.   
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as mold or bacteria, which might in-turn cause adverse health effects (IOM 2004).  Building 
dampness could also cause increased emissions of some chemical pollutants from materials and 
surfaces (IOM 2004).  Research has not yet determined the causal agent(s) (IOM 2004).   
 
Implication of building dampness as a public health problem requires that the presence of 
building dampness increase health risks, and also that a substantial proportion of the population 
is exposed to dampness.  Most available data indicate that at least 20% of homes have dampness 
problems or visible mold (IOM 2004).  In addition, the adverse consequences of building 
dampness go beyond health effects and the related personal and economic costs.  Dampness 
causes structural damage to buildings that is expensive to repair.  Also, mold contamination 
resulting from building dampness often precipitates very expensive remediation efforts (Levin 
2005).   
 
Despite the current lack of proof that dampness or mold actually causes these health effects, 
available knowledge suggests that it is prudent to prevent building dampness and mold and to 
take corrective actions where such conditions occur (IOM 2004).  Many of the preventive and 
corrective actions are straightforward.  Examples include better training of those in the 
construction industry about the means of reducing dampness risks and instituting ongoing 
preventive maintenance programs to identify and quickly remedy roof and plumbing leaks or 
other causes of moisture accumulation or mold growth.  
 
Limitations in this analysis 
These meta-analyses used data only from studies referenced in the IOM’s recent critical review 
(IOM 2004), and, thus, omitted more recently published studies.  However, as research on 
dampness and mold has occurred for over two decades, it is unlikely that studies published in the 
last few years (i.e., since 2003) would substantially affect the outcomes of our meta-analyses. 
 
Because our meta-analyses used only studies cited in the IOM’s review, we have effectively 
relied on the IOM to select studies of suitable quality.  All original studies were published in 
refereed archival journals, which is one indicator of study quality.  The IOM did not precisely 
describe other study selection criteria, but in general their reviews consider only studies without 
significant evident methodological flows, with control for major known confounding factors via 
the study design or method of data analysis, and with a statistical analysis of study data.  
Remaining errors from any confounding and bias in the reviewed studies may be reflected in 
results of the meta-analyses, although some of these, due to the combination of different studies, 
may cancel out and have a modest impact on results of the meta-analyses.  
 
One potential source of bias pertains to the methods used to determine whether a building had 
dampness or mold.  Most studies have relied on the occupants to report whether dampness or 
mold is present in their home.  It is possible that homeowners with respiratory health problems 
would be more aware of, and thus, more likely to report dampness and mold than homeowners 
without such health problems.  If true, this reporting bias would lead to overestimated ORs in the 
original studies and corresponding overestimated ORs from our meta-analyses.  On the other 
hand, as homeowners within each study would report dampness or mold in a relatively 
unstandardized way, the resulting random error in assessment could result in what is called 
“nondifferential exposure misclassification,” leading to underestimated ORs in those studies.  
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Alternately, some studies have relied on trained surveyors who inspected buildings for signs of 
dampness and mold.  Surveyors would have used standardized methods of assessment for 
dampness or mold within each study, thus reducing that source of inaccuracy. Surveyors, 
however, are likely to have missed indicators of dampness and mold that were not present or 
evident during their brief survey, leading to random errors in exposure assessment and 
consequent underestimates of any true risk.  In general, both types of studies have found 
increased risks of respiratory health effects among occupants of homes with dampness and 
molds.  Unfortunately, we do not have a sufficient number of studies with surveyor-assessed 
dampness and mold to enable separate meta-analyses.  
 
Reviews and meta-analyses are also subject to publication bias – the overestimation of summary 
estimates of association that can occur because studies with positive findings are published more 
often (IOM 2004, pg 20) and more quickly than studies that failed to find significant 
associations.  Publication bias would bias the results of our meta-analyses upward; i.e., estimated 
ORs based on all published studies would exceed true central estimates based on all performed 
studies.  While there are statistical tools available that enable one to check for evidence of 
publication bias, it remains difficult to quantify the extent of publication bias or to make 
corrections in the resulting central estimates of ORs.  
 
It is important to note that the confidence intervals associated with our central estimates of ORs 
reflect only the probabilistic or chance uncertainties.  The full uncertainties in the magnitudes of 
increased health risks are likely to be larger because they would also include the potential 
uncontrolled confounding and bias noted above. 
 
Asthma development -- comparison to findings of IOM 
 
The IOM Committee found limited or suggestive evidence of an association between building 
dampness and asthma development, and inadequate or insufficient evidence to determine 
whether an association exists between mold and asthma development.  These statements are 
consistent with the results of our meta-analysis.  We calculated ORs of 1.32 and 1.39 for asthma 
development if the home had dampness or mold; however, neither CI excluded unity.  Also, our 
meta analysis for asthma development was based on only three studies and the definitions for 
asthma development used in these three studies were variable.  
 
CONCLUSIONS 
 
Based on our meta-analyses, building dampness and mold are associated with 30% to 80% 
increases in a variety of respiratory and asthma-related health outcomes and the associations are 
statistically significant in nearly all cases.  Given what is known today, it would be prudent to 
avoid building dampness and mold problems and to take corrective actions where such problems 
occur. 
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Appendix 1.  Description of studies included in the meta-analyses. 
 
Table A1.1 Studies with upper respiratory tract symptoms 
Subjects Author Year Risk Factor Symptomx 
Engvall 2002 moldy odor & water leakage in preceding 5 years nasal 
rhinitis surveyor assessed moisture 
sinusitis 
rhinitis 
Koskinen 1999 
mold 
sinusitis 
flood Wan 1999 
mold 
nasal congestion or runny nose 
adults 
Wieslander 1999 damp concrete floor irritated, stuffy, or runny nose 
men 
women 
Brunekreef 1992 damp stains or mold growth in last 2 years allergy 
damp ever Brunekreef 1989 
mold ever 
hay fever 
nasal congestion mold odor in past year 
nasal excretion 
nasal congestion 
Jaakkola 1993 
water damage >1 year ago 
nasal excretion 
rhinitis Koskinen 1999 surveyor assessed moisture 
sinusitis 
Zacharasiewicz 2000 damp nasal 
children 
Kilpeläinen 2001 visible mold allergic rhinitis 
students Kilpeläinen 2001 visible mold or damp stains or water damage allergic rhinitis 
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Table A1.2 Studies with cough as an outcome 
Subjects Author Year Risk Health outcome 
Engvall 2001 moldy odor & major water leakage cough 
Engvall 2001 moldy odor & signs of hi humidity cough 
Gunnbjörnsdottir 2003 water damage or mold long-term cough 
Koskinen 1999 moisture cough w/ phlegm 
Koskinen 1999 moisture cough w/o phlegm 
Koskinen 1999 moisture night cough 
Koskinen 1999 mold cough w/ phlegm 
Koskinen 1999 mold cough w/o phlegm 
Koskinen 1999 mold night cough 
adults 
Pirhonen 1996 mold or damp cough 
men Brunekreef 1992 damp stains or mold growth last 2 yrs cough 
men Waegemaekers 1989 damp cough 
women Brunekreef 1992 damp stains or mold growth last 2 yrs cough 
women Waegemaekers 1989 damp cough 
Andriessen 1998 moisture stains cough 
Andriessen 1998 mold cough 
Austin 1997 damp cough 
Austin 1997 mold cough 
Brunekreef 1989 damp ever cough 
Brunekreef 1989 mold ever cough 
Dales 1991 flood cough 
Dales 1991 moisture cough 
Dales 1991 Mold site cough 
Dales 1991 Mold sites cough 
Dales 1991 mold or damp cough 
Dales 1999 mold or mildew night cough or wheeze 
Dijkstra 1990 mold & damp cough 
Dijkstra 1990 mold or damp cough 
Jaakkola 1993 mold odor past yr persistent cough 
Jaakkola 1993 water damage >1 yr ago persistent cough 
Jedrychowski 1998 mold or damp cough 
Koskinen 1999 moisture cough w/ phlegm 
Koskinen 1999 moisture cough w/o phlegm 
Koskinen 1999b moisture night cough 
Verhoeff 1995 damp cough 
Verhoeff 1995 mold cough 
Waegemaekers 1989 damp day or night cough 
children 
Waegemaekers 1989 damp morning cough 
infants w/ asthmatic sibling Gent 2002 water leaks cough 
infants w/ asthmatic sibling + 
asthmatic mother 
infants w/ asthmatic sibling + 
non-asthmatic mother 
Belanger 2003 persistent mold or mildew previous year persistent cough 
adolescents Nicolai 1998 past or present damp cough 
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 Table A1.3 Studies with wheeze as an outcome. 
Subjects Author Year Risk Outcome 
Gunnbjörnsdottir 2003 water damage or mold wheeze 
>1 signs of dampness  
damp floor 
visible mold on indoor surfaces 
moldy odor 
adults 
Norbäck 1999
water damage or flood 
wheeze 
Brunekreef 1992 damp stains or mold growth in last 2 yrs wheeze men 
Waegemaekers 1989 damp wheeze 
Brunekreef 1992 damp stains or mold growth in last 2 yrs wheeze women 
Waegemaekers 1989 damp wheeze 
1989 damp ever wheeze Brunekreef 
1989 molds ever wheeze 
flood 
moisture 
mold site 
mold sites 
Dales 1991
mold or damp 
wheeze 
mold & damp Dijkstra 1990
mold or damp 
wheeze 
mold odor in past year Jaakkola 1993
water damage >1 yr ago 
persistent 
wheeze 
Jedrychowski 1998 mold or damp wheeze 
basement water 
mold 
mold, water damage, basement water, or water 
condensation 
water condensation 
Maier 1997
water damage 
wheeze 
Slezak 1998 mold or damp wheeze 
Strachan 1990 mold wheeze 
Taskinen 1999 damp wheeze 
children 
Waegemaekers 1989 damp wheeze 
infants w/ asthmatic sibling Gent 2002 Water leaks wheeze 
infants w/ asthmatic sibling 
+ asthmatic mother 
infants w/ asthmatic sibling, 
+ nonasthmatic mother 
Belanger 2003 persistent mold or mildew in previous year wheeze 
damp adolescent Nicolai 1998
damp, adjusted for mite allergen concentration 
wheeze 
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Table A1.4 Studies with asthma diagnosis as an outcome. 
Subjects Author Year Risk Outcome description* 
indoor damp 
visible mold Hu 1997 
water leaks 
Dr. dx asthma 
>1 damp 
damp floor 
moldy odor 
visible mold 
adults 
Norbäck 1999 
water damage or flood 
current asthma defined as 
combination of bronchial hyper-
responsiveness and at least one 
asthma sx in last year 
men Brunekreef 1992 damp or mold Dr. dx. asthma 
men Waegemaekers 1989 damp Dr. dx.asthma or dyspnea 
women Brunekreef 1992 damp or mold Dr. dx. asthma 
women Waegemaekers 1989 damp Dr. dx asthma or dyspnea 
Jedrychowski 1998 mold or damp Dr. dx. asthma 
Dr. dx atopic asthma 
Dr. dx atopic or non-atopic asthma Rönmark 1999 damp home 
Dr. dx non-atopic asthma 
Slezak 1998 damp or mold Dr. or nurse dx asthma 
children 
Waegemaekers 1989 damp Dr. dx asthma or dyspnea 
damp 
damp or condensation current home 
damp previous home 
mold 
severe damp 
children & 
adults Williamson 1997 
significant mold 
Dr. dx asthma  
Abbreviations:  sx = symptom; dx = diagnosis 
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 Table A1.5 Studies with current asthma as an outcome. 
Subjects Author Year Risk Outcome description* 
indoor damp 
visible mold 
Hu 1997 
water leaks 
Dr. dx asthma + sx or medication 
in past year 
>1 damp 
damp floor 
moldy odor 
visible mold 
adults 
Norbäck 1999 
water damage or flood 
current asthma defined as 
combination of bronchial hyper-
responsiveness and at least one 
asthma sx in last year 
damp ever Brunekreef 1989 
mold 
Dr. dx asthma in past year 
flood 
moisture 
mold 
mold 2 
Dales 1991 
mold or damp 
Current asthma confirmed by Dr. 
Dekker 1991 damp or visible mold Dr. dx asthma + current sx 
any damp indicator ever 
moisture > 1yr ago 
moisture past yr 
mold odor past yr 
visible mold past yr 
Jaakkola 1993 
water damage >1 yr ago 
current Dr. dx asthma 
Taskinen 1999 damp home Dr. dx asthma + sx 
children 
Yang 1997 damp home current Dr. diagnosed asthma 
visible mold 
students Kilpeläinen 2001 
visible mold, damp stains or water damage 
current Dr. dx asthma 
adolescent Nicolai 1998 past or present damp >5 asthma attacks previous yr
Abbreviations:  sx = symptom; dx = diagnosis 
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Table A1.6 , Studies with asthma development as an outcome. 
Subjects Author Year Risk Outcome description* 
damp stains or paint peeling 
visible mold or odor Jaakkola 2002 
water damage 
newly Dr. dx asthma in past year 
damp 
damp or visible mold Thorn 2001 
visible mold 
Dr. dx asthma since age > 16 
adults 
Yang 1998 damp or mold or water damage first-time Dr. dx asthma 
Abbreviations:  dx = diagnosis 
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Appendix 2.  Excluded Studies 
Author Year Excluded from Reason for exclusion* 
Belanger 2003 cough, wheeze excluded measured conc of microbial agent 
Dales 1999 upper respiratory sx some sx not upper respiratory sx 
Dijkstra 1990 asthma sx no clear diagnosis of asthma 
Engvall 2002 upper respiratory sx excluded throat sx 
Gent 2002 cough, wheeze excluded measured conc. of microbial agent; or excluded humidifier as risk factor 
Infante-Rivard 1993 newly diagnosed excluded humidifier as risk factor 
Jaakkola 2002 newly diagnosed asthma Excluded studies of risks at workplaces  
Kilpeläinen 2001 common cold>4/yr excluded cold sx 
Koskinen 1999 sore throat excluded throat sx 
Mohamed 1995 asthma sx socio-economic status and housing conditions of the Kenyan subjects was atypical of that in other studies 
Nafstad 1998 bronchial obstr age < 2 too early for asthma diagnosis 
Park 2001 wheeze excluded measured conc. of microbial agent 
asthma sx ORs are for atopy and should not be used for asthma sx Pirhonen 1996 
dry or sore throat excluded throat sx 
Rylander 1998 cough, wheeze excluded risk factors at school  
excluded cold sx 
humidity is not used in our study as an indicator of a dampness 
or mold 
Rylander 2000 cold, sore throat 
excluded throat sx 
Taskinen 1999 asthma sx, cough, wheeze excluded studies of risks of dampness at school 
Thorn 1998 cough, UR excluded measured conc. of microbial agent 
Waegemaekers 1989 wheeze includes shortness of breath, asthma excluded measured conc. of microbial agent 
Wever-Hess 2000 asthma  age < 2 too early for asthma diagnosis 
Wieslander 1999 UR excluded eye sx 
Yazicioglu 1998 asthma sx excluded self-reported high humidity as risk factor 
Zock 2002 wheeze  meta-analysis itself 
Øie 1999 bronchial obstruction age < 2 too early for asthma diagnosis 
  Abbreviations:  sx= symptom 
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 Appendix 3.  Example of original data and results of a meta- analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OR for wheeze, random effects model for independent studies
.4 1 2 3 4 5 6 7 8 910 20 30
 Combined Combined OR (95% CI) = 1.65 (1.48-1.83) 
 
Figure A3-1.  Odds ratios and confidence intervals for wheeze from original studies and from a 
meta-analysis performed using the random effects model and assuming independent sub-studies.  
The width of the boxes (some so small they appear as points) is proportional to the precision 
(inverse of variance) of the study and the ends of the horizontal lines represent lower and upper 
95% confidence limits.  The dark vertical line is located at an odds ratio of unity which 
corresponds to no increased risk of wheeze, while nearly all the reported odds ratios are greater 
than unity indicating an increase in risk with dampness and mold.  The central estimate from the 
meta-analysis is indicated by the light dashed vertical line and the left- and right-side points of 
the diamond at the bottom (labeled combined) of the figure indicate the lower and upper 95% 
confidence limits from the meta-analysis. 
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